Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry researchers · Friday, August 19, 2022 · 586,798,865 Articles · 3+ Million Readers

Tumor Genomic Market Growth , High Demands, Trends | Top Company Shares, Regional Forecasts to 2028

Emergen Research Logo

Emergen Research Logo

Increasing number of cancer cases, rising government initiatives and projects, new drug developments, and increasing demand for cancer-specific diagnostics

Tumor Genomic Market Size – USD 21.42 Billion in 2020, Market Growth – at a CAGR of 12.8%, Market Trends – Next generation sequencing techniques and new drug discoveries.”
— Emergen Research

VANCOUVER, BC, CANADA, June 27, 2022 /EINPresswire.com/ -- The global tumor genomics market is expected to reach a market size of 56.54 Billion by 2028 and register a double-digit CAGR over the forecast period, according to latest analysis by Emergen Research. The steady projected growth can be attributed to technological innovations in the field of genomics. Mergers and acquisitions between key players in the field is another key factor driving market growth. Increasing research on cancer, usage of genomic systems among academics and government institutions, and decreasing cost of sequencing is contributing significantly to growth in cancer diagnostics.

The Global Tumor Genomic Market report brings into light key market dynamics of the sector. This intelligence report includes investigations based on Current scenarios, Historical records, and Future predictions. The report contains different market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, diagrams, graphs, pie charts, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary and SWOT analysis.

Request a sample copy of the global Tumor Genomic market report @ https://www.emergenresearch.com/request-sample/531

The global Tumor Genomic market consists of various segments, including product type outlook, application spectrum, end-user overview, leading regions, and the competitive analysis. The report further provides information regarding the value chain, emerging market sectors, and the technological advancements in the industry to benefit readers and businesses looking to invest in this industry.

Key Market Competitors Profiled in the Report:

Thermo Fisher Scientific Inc., Illumina, Inc., QIAGEN, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Pacific Biosciences of California, Inc., NeoGenomics Laboratories, Inc., Myriad Genetics, Inc., and PerkinElmer.

The report emphasizes the demands and ongoing trends of the global Tumor Genomic market, more importantly, across the major regions of the market. Additionally, our analysts have included SWOT analysis and Porter’s Five Forces analysis in the report to offer a better understanding of the competitive spectrum of this ever-evolving industry. Moreover, the report sheds light on the cutting-edge expansion strategies adopted by the market contenders, such as mergers & acquisitions, joint ventures, partnerships & collaborations, new product launches, and brand promotions. 

For more details of the Tumor Genomic Market Report, visit @ https://www.emergenresearch.com/industry-report/tumor-genomics-market

Key Highlights of Report

In September 2018, Cancer Genetics Inc. and NovellusDx Ltd. signed a merger agreement in order to combine their data associated to tumor anatomy. The aim behind the merger is to enhance and accelerate the therapeutic development to improve treatment success rates for companies. With the proprietary technology and machine learning technology of NovellusDX Ltd., Cancer Genetics aims to form a leading oncology-focused precision medicine company.

Biomarkers play an important role in the detection of cancer and it may be used to detect early cancer symptoms or to perform differential diagnosis of cancerous tumors.

Revenue from the tumor genomic market in Asia Pacific is expected to expand at a rapid CAGR during the forecast period. This can be attributed to rising government funding for cancer detection and awareness, and introduction of state-of-the-art research institutions.

Emergen Research has segmented the global tumor genomic market on the basis of technique, application, end-use, and region:

Technique Outlook (Revenue, USD Billion; 2021–2028)

Next Generation Sequencing Technique (NGS)

Polymerase Chain Reaction (PCR)

Microarray

In-Situ Hybridization (ISH)

Immunohistochemistry (ICH)

Others (Mass Spectrometry and Flow Cytometry)

Application Outlook (Revenue, USD Billion; 2021–2028)

Diagnostics and Monitoring

Drug Discovery and Development

Biomarker Discovery

End-use Outlook (Revenue, USD Billion; 2021–2028)

Academics and Research Organizations

Hospitals and Ambulatory Clinics

Clinical and Diagnostic Laboratories

Biotechnology and Pharmaceutical Company

Buy the Full Research Report of Global Tumor Genomic Market@ https://www.emergenresearch.com/select-license/531

Major Geographies Covered in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

In addition, the competitive dynamics of the Tumor Genomic market are evaluated in detail during the study. Current and future trends shaping the progress of the industry are evaluated during the study, which offers a review of the major technology trends expected to dominate the during the forecast period, The assessment report not only identifies but also anticipates and satisfies business owners’ questions pertaining to the dramatic shift in customer preferences, spending power and consumer demands worldwide. Along with this, import and export status, demand and supply, distribution channel, cost structure, gross margin and profits generated across different segments are thoroughly examined.

Target Audience of the Report:

Leading Companies

Large, medium-sized, and small enterprises

Investors

Value-Added Resellers (VARs)

Venture capitalists

Third-party knowledge providers

The global Tumor Genomic market report evaluates the latest economic scenario in terms of value and volume. It highlights the key growth drivers, restraints, production capacity, demand & supply ratio, import/export status, growth rate, and other critical aspects. Additionally, the report also performs SWOT analysis, Porter’s Five Forces analysis, speculation attainability investigation, and venture return investigation.

Key Benefits of Buying the Global Tumor Genomic Report:

Comprehensive analysis of the changing competitive landscape

Assists in decision making processes for the businesses along with detailed strategic planning methodologies

The report offers an 8-year forecast and assessment of the Global Tumor Genomic Market

Helps in understanding the key product segments and their estimated growth rate

In-depth analysis of market drivers, restraints, trends, and opportunities

Comprehensive regional analysis of the Global Tumor Genomic Market

Extensive profiling of the key stakeholders of the business sphere

Detailed analysis of the factors influencing the growth of the Global Tumor Genomic Market

Ask here for more customization study@ https://www.emergenresearch.com/request-for-customization/531

Thank you for reading our report. For further details or to inquire about customization, please get in touch with us. We assure you that your report will be designed as per your requirements.

Latest Blog Articles Published by Emergen Research:

https://medium.com/@ishadeshpande15/functional-ingredients-market-study-provides-worldwide-overview-and-forecast-by-2021-2028-3b55312e0872

https://medium.com/@ishadeshpande15/structural-insulated-panels-market-study-provides-worldwide-overview-and-forecast-by-2021-2028-c4b714abd74c

https://medium.com/@ishadeshpande15/water-and-wastewater-treatment-market-study-provides-worldwide-overview-and-forecast-by-2020-2027-25004795746a

https://medium.com/@ishadeshpande15/textile-chemicals-market-investment-opportunities-industry-share-trend-analysis-report-to-2028-781bd36c05d4

https://medium.com/@ishadeshpande15/ehealth-market-study-provides-worldwide-overview-and-forecast-by-2020-2027-f619123eb07a

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn

The global tumor genomics market is expected to reach a market size of 56.54 Billion by 2028

Powered by EIN Presswire
Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release